Invention Grant
- Patent Title: Human cytomegalovirus neutralising antibodies and use thereof
- Patent Title (中): 人巨细胞病毒中和抗体及其用途
-
Application No.: US14041799Application Date: 2013-09-30
-
Publication No.: US09149524B2Publication Date: 2015-10-06
- Inventor: Antonio Lanzavecchia , Annalisa Macagno
- Applicant: Institute for Research in Biomedicine
- Applicant Address: CH Bellinzona
- Assignee: Institute for Research in Biomedicine
- Current Assignee: Institute for Research in Biomedicine
- Current Assignee Address: CH Bellinzona
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio, Esq.
- Priority: GB0700133.2 20070104
- Main IPC: A61K39/42
- IPC: A61K39/42 ; A61K39/395 ; C07K16/08
Abstract:
The invention relates to neutralizing antibodies which are specific for human cytomegalovirus and bind with high affinity as well as immortalized B cells that produce such antibodies. The invention also relates to the epitopes that the antibodies bind to as well as the use of the antibodies and the epitopes in screening methods as well as the diagnosis and therapy of disease.
Public/Granted literature
- US20140056914A1 HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF Public/Granted day:2014-02-27
Information query
